ISSUES IN PLANNING AND INTERPRETING ACTIVE CONTROL EQUIVALENCE STUDIES

被引：54

作者：

MAKUCH, R ^{[1
]}

JOHNSON, M ^{[1
]}

机构：

[1] GH BESSELAAR ASSOCIATES,PRINCETON,NJ 08540

来源：

JOURNAL OF CLINICAL EPIDEMIOLOGY | 1989年 / 42卷 / 06期

关键词：

D O I：

10.1016/0895-4356(89)90146-7

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：503 / 511

页数：9

共 52 条

[1]

BEGIN P, 1987, ANN INTERN MED, V106, P474, DOI 10.7326/0003-4819-106-3-474_3

[2] PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].

BLACKWELDER, WC .

CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353

[3] AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA [J].

BOUSSER, MG ;

ESCHWEGE, E ;

HAGUENAU, M ;

LEFAUCCONNIER, JM ;

THIBULT, N ;

TOUBOUL, D ;

TOUBOUL, PJ .

STROKE, 1983, 14 (01) :5-14

[4]

BULPITT CJ, 1987, LANCET, V1, P494

[5] RANDOMIZED CLINICAL-TRIALS - PERSPECTIVES ON SOME RECENT IDEAS [J].

BYAR, DP ;

SIMON, RM ;

FRIEDEWALD, WT ;

SCHLESSELMAN, JJ ;

DEMETS, DL ;

ELLENBERG, JH ;

GAIL, MH ;

WARE, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (02) :74-80

[6]

Canadian Cooperative Study Group, 1978, N Engl J Med, V299, P53

[7] A RANDOMIZED TRIAL OF ASPIRIN AND SULFINPYRAZONE IN PATIENTS WITH TIA [J].

CANDELISE, L ;

LANDI, G ;

PERRONE, P ;

BRACCHI, M ;

BRAMBILLA, G .

STROKE, 1982, 13 (02) :175-179

[8]

COX DR, 1984, CURRENT PROBLEMS CLI, P41

[9] WHEN WAS A NEGATIVE CLINICAL-TRIAL BIG ENOUGH - HOW MANY PATIENTS YOU NEEDED DEPENDS ON WHAT YOU FOUND [J].

DETSKY, AS ;

SACKETT, DL .

ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (04) :709-712

[10] SIGNIFICANCE TESTING TO ESTABLISH EQUIVALENCE BETWEEN TREATMENTS, WITH SPECIAL REFERENCE TO DATA IN FORM OF 2 X 2 TABLES [J].

DUNNETT, CW ;

GENT, M .

BIOMETRICS, 1977, 33 (04) :593-602

← 1 2 3 4 5 6 →